These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10708879)

  • 1. Ion pair skin transport of a zwitterionic drug, cephalexin.
    Hatanaka T; Kamon T; Morigaki S; Katayama K; Koizumi T
    J Control Release; 2000 May; 66(1):63-71. PubMed ID: 10708879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convective solvent flow across the skin during iontophoresis.
    Kim A; Green PG; Rao G; Guy RH
    Pharm Res; 1993 Sep; 10(9):1315-20. PubMed ID: 8234169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis.
    Tang H; Mitragotri S; Blankschtein D; Langer R
    J Pharm Sci; 2001 May; 90(5):545-68. PubMed ID: 11288100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic.
    Pasini CE; Indelicato JM
    Pharm Res; 1992 Feb; 9(2):250-4. PubMed ID: 1553350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ceramic component on cephalexin release from bioactive bone cement consisting of Bis-GMA/TEGDMA resin and bioactive glass ceramics.
    Otsuka M; Fujita H; Nakamura T; Kokubo T
    Biomed Mater Eng; 2001; 11(1):11-22. PubMed ID: 11281575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of food on absorption of cefadroxil and cephalexin in dogs.
    Campbell BG; Rosin E
    J Vet Pharmacol Ther; 1998 Oct; 21(5):418-20. PubMed ID: 9811445
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of cephalexin in calves after intravenous and subcutaneous administration.
    Garg SK; Chaudhary RK; Srivastava AK
    Acta Vet Hung; 1996; 44(2):195-201. PubMed ID: 8908743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced in vitro percutaneous penetration of salicylate by ion pair formation with alkylamines.
    Kadono M; Kubo K; Miyazaki H; Tojyo N; Nakagawa S; Miyashita K; Imanishi T; Rytting JH; Mayumi T
    Biol Pharm Bull; 1998 Jun; 21(6):599-603. PubMed ID: 9657045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in situ evidence for the contribution of Labrasol and Gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine.
    Koga K; Kawashima S; Murakami M
    Eur J Pharm Biopharm; 2002 Nov; 54(3):311-8. PubMed ID: 12445561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of medium-chain glycerides on physiological properties of rabbit intestinal epithelium in vitro.
    Yeh PY; Smith PL; Ellens H
    Pharm Res; 1994 Aug; 11(8):1148-54. PubMed ID: 7971716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic comparison of cefadroxil and cephalexin after administration of 250, 500 and 1000 mg solution doses.
    Barbhaiya RH
    Biopharm Drug Dispos; 1996 May; 17(4):319-30. PubMed ID: 8743403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of degradation of cefazolin and cephalexin in aqueous solution.
    Rattie ES; Guttman DE; Ravin LJ
    Arzneimittelforschung; 1978; 28(6):944-8. PubMed ID: 35181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport characteristics of ceftibuten, cefixime and cephalexin across human jejunal brush-border membrane.
    Sugawara M; Iseki K; Miyazaki K; Shiroto H; Kondo Y; Uchino J
    J Pharm Pharmacol; 1991 Dec; 43(12):882-4. PubMed ID: 1687593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Enterued administration on the intestinal absorption of orally active cefem antibiotics].
    Iseki K; Satoh Y; Sugawara M; Miyazaki K
    Yakugaku Zasshi; 1994 Apr; 114(4):233-40. PubMed ID: 8201544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porous resins as a cavitation enhancer for low-frequency sonophoresis.
    Terahara T; Mitragotri S; Langer R
    J Pharm Sci; 2002 Mar; 91(3):753-9. PubMed ID: 11920760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of transport of quinapril in Caco-2 cell monolayers: comparison with cephalexin.
    Hu M; Zheng L; Chen J; Liu L; Zhu Y; Dantzig AH; Stratford RE
    Pharm Res; 1995 Aug; 12(8):1120-5. PubMed ID: 7494822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of cephalexin through gellan gum beads: effect of formulation parameters on entrapment efficiency, size, and drug release.
    Agnihotri SA; Jawalkar SS; Aminabhavi TM
    Eur J Pharm Biopharm; 2006 Jul; 63(3):249-61. PubMed ID: 16621483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.
    Dantzig AH; Bergin L
    Biochim Biophys Acta; 1990 Sep; 1027(3):211-7. PubMed ID: 2397233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal iontophoresis and solute penetration across excised human skin.
    Singh P; Anliker M; Smith GA; Zavortink D; Maibach HI
    J Pharm Sci; 1995 Nov; 84(11):1342-6. PubMed ID: 8587053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ionization on absorption of cephalosporins.
    DeYoung JL; Tan HG; Huber HE; Zoglio MA
    J Pharm Sci; 1978 Mar; 67(3):320-3. PubMed ID: 25323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.